⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PFE News
Pfizer Inc.
Dyspnea Treatment Market 2026-2031 - Rising Prevalence of Respiratory and Cardiovascular Diseases to Drive Growth
globenewswire.com
PFE
AZN
TEVA
AMRX
BHC
Pulmonary Edema (2026-2031) - Rising Prevalence of Cardiovascular Diseases Drives Market Growth
globenewswire.com
ABBV
AZN
BSX
BMY
EL
LLY
JNJ
MRK
NVS
PFE
SNY
VTRS
Babesiosis Treatment 2026-2031 - Rising Incidence of Tick-Borne Diseases Drives Market Growth
globenewswire.com
AMRX
GSK
PFE
VTRS
Upper Respiratory Tract Infection Treatment (2026-2031) - Rising Prevalence of Respiratory Infections Drives Market Growth
globenewswire.com
ABT
ABBV
ALC
AZN
BMY
CI
DDS
JNJ
MRK
NVS
PFE
SNY
TEVA
VTRS
Vasomotor Symptoms 2026-2031 - Growing Demand for Non-Hormonal Menopause Treatments Drives Market Growth
globenewswire.com
PFE
TEVA
VTRS
Global Cardiometabolic Drugs 2026-2031 - Rising Cardiometabolic Disease Prevalence Drives Market Growth
globenewswire.com
LLY
NVO
AZN
BMY
PFE
MRK
AMGN
ABBV
GILD
Cerebral Palsy Treatment (2026-2031) - Advances in Rehabilitation and Assistive Technologies Drive Market Growth
globenewswire.com
ABBV
ZBH
SYK
NTRA
TEVA
PFE
Hubble, the UK's largest flexible office marketplace, launches in the US
prnewswire.com
GOOGL
AMZN
MSFT
CRM
NOW
IBM
INTC
NVDA
AMD
QCOM
MU
AMAT
LRCX
ASML
ADI
TXN
NXPI
ON
MRVL
SNPS
CDNS
WDC
SE
SHOP
PFE
CAL
Global PARP Inhibitors Cancer Therapy Market Report 2026: Approved Therapies Dosage, Price, Sales & Clinical Trials Insight 2031
globenewswire.com
AZN
PFE
GSK
BMY
ABBV
Active Pharmaceutical Ingredients (API) Market Report 2026-2036 Just Released — Analyses Synthetic, Biotech, Traditional and Highly Potent APIs
globenewswire.com
MRK
PFE
NVS